1. From the Cellular and Molecular Tumour Pathology, Department of Oncology and Pathology, Cancer Centre Karolinska R8:04, Karolinska Institute, Stockholm, Sweden;2St. Erik’s Eye Hospital, Stockholm, Sweden; the
2. St. Erik’s Eye Hospital, Stockholm, Sweden; the
3. From the Cellular and Molecular Tumour Pathology, Department of Oncology and Pathology, Cancer Centre Karolinska R8:04, Karolinska Institute, Stockholm, Sweden;
4. Department of Hematology and Immunology, Vrije Universiteit, Brussels, Belgium; and the
5. Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden.